Switch to: References

Add citations

You must login to add citations.
  1. Ethical Issues of Using CRISPR Technologies for Research on Military Enhancement.Marsha Greene & Zubin Master - 2018 - Journal of Bioethical Inquiry 15 (3):327-335.
    This paper presents an overview of the key ethical questions of performing gene editing research on military service members. The recent technological advance in gene editing capabilities provided by CRISPR/Cas9 and their path towards first-in-human trials has reinvigorated the debate on human enhancement for non-medical purposes. Human performance optimization has long been a priority of military research in order to close the gap between the advancement of warfare and the limitations of human actors. In spite of this focus on temporary (...)
    Download  
     
    Export citation  
     
    Bookmark   8 citations  
  • Untangling the Promises of Human Genome Editing.Katherine Drabiak - 2018 - Journal of Law, Medicine and Ethics 46 (4):991-1009.
    This article traces the rapid progression of policy pertaining to human genome germline modifications using genome editing. It provides an overview of how one fertility physician implemented and advertised experimental techniques as part of his fertility clinic services, examines US law and policy, and assesses the impact of rhetoric influencing global policy and interpretation of the law. This article provides an in-depth examination of the medical rationale driving the acceptance of genome editing human embryos in two contexts: to cure disease (...)
    Download  
     
    Export citation  
     
    Bookmark   2 citations  
  • The ‘serious’ factor in germline modification.Erika Kleiderman, Vardit Ravitsky & Bartha Maria Knoppers - 2019 - Journal of Medical Ethics 45 (8):508-513.
    Current advances in assisted reproductive technologies aim to promote the health and well-being of future children. They offer the possibility to select embryos with the greatest potential of being born healthy (eg, preimplantation genetic testing) and may someday correct faulty genes responsible for heritable diseases in the embryo (eg, human germline genome modification (HGGM)). Most laws and policy statements surrounding HGGM refer to the notion of ‘serious’ as a core criterion in determining what genetic diseases should be targeted by these (...)
    Download  
     
    Export citation  
     
    Bookmark   9 citations